Busca un médico

Jim T. McCarthy, M.D.

  1. Internist
  2. Nephrologist
Solicite una Consulta

Publicaciones

  1. King BJ, El-Azhary RA, McEvoy MT, Shields RC, McBane RD, McCarthy JT, Davis MDP. Direct oral anticoagulant medications in calciphylaxis. Int J Dermatol. 2017 Oct; 56 (10):1065-1070 Epub 2017 Aug 30
    View PubMed
  2. McCarthy JT, El-Azhary RA, Patzelt MT, Weaver AL, Albright RC, Bridges AD, Claus PL, Davis MD, Dillon JJ, El-Zoghby ZM, Hickson LJ, Kumar R, McBane RD, McCarthy-Fruin KA, McEvoy MT, Pittelkow MR, Wetter DA, Williams AW. Survival, Risk Factors, and Effect of Treatment in 101 Patients With Calciphylaxis. Mayo Clin Proc. 2016 Oct; 91 (10):1384-1394
    View PubMed
  3. El-Azhary RA, Patzelt MT, McBane RD, Weaver AL, Albright RC, Bridges AD, Claus PL, Davis MD, Dillon JJ, El-Zoghby ZM, Hickson LJ, Kumar R, McCarthy-Fruin KA, McEvoy MT, Pittelkow MR, Wetter DA, Williams AW, McCarthy JT. Calciphylaxis: A Disease of Pannicular Thrombosis. Mayo Clin Proc. 2016 Oct; 91 (10):1395-1402
    View PubMed
  4. Sakhuja A, Wright RS, Schold JD, McCarthy JT, Williams AW, Amer H, Albright RC. National Impact of Maintenance Dialysis or Renal Transplantation on Outcomes Following ST Elevation Myocardial Infarction. Am J Nephrol. 2016; 44: (5)329-338.
    View PubMed
  5. Albright RC Jr, Dillon JJ, Hocum CL, Stubbs JR, Johnson PM, Hickson LJ, Williams AW, Dingli D, McCarthy JT. Total Red Blood Cell Transfusions for Chronic Hemodialysis Patients in a Single Center, 2009-2013. Nephron. 2016; 133 (1):23-34 Epub 2016 Apr 16
    View PubMed
  6. Hickson LJ, Chaudhary S, Williams AW, Dillon JJ, Norby SM, Gregoire JR, Albright RC Jr, McCarthy JT, Thorsteinsdottir B, Rule AD. Predictors of outpatient kidney function recovery among patients who initiate hemodialysis in the hospital. Am J Kidney Dis. 2015 Apr; 65 (4):592-602 Epub 2014 Nov 05
    View PubMed
  7. Hickson LJ, Crowson CS, Gabriel SE, McCarthy JT, Matteson EL. Development of reduced kidney function in rheumatoid arthritis. Am J Kidney Dis. 2014 Feb; 63 (2):206-13 Epub 2013 Oct 04
    View PubMed
  8. McCarthy JT, Hocum CL, Albright RC, Rogers J, Gallaher EJ, Steensma DP, Gudgell SF, Bergstralh EJ, Dillon JC, Hickson LJ, Williams AW, Dingli D. Biomedical system dynamics to improve anemia control with darbepoetin alfa in long-term hemodialysis patients. Mayo Clin Proc. 2014 Jan; 89 (1):87-94
    View PubMed
  9. Schoonover KL, Hickson LJ, Norby SM, Hogan MC, Chaudhary S, Albright RC Jr, Dillon JJ, McCarthy JT, Williams AW. Risk factors for hospitalization among older, incident haemodialysis patients. Nephrology (Carlton). 2013 Nov; 18 (11):712-7
    View PubMed
  10. Thomas LF, McCarthy JT, Wenger DE, Norby SM. Digital manifestations of tertiary hyperparathyroidism. Kidney Int. 2012 Sep; 82(6):724.
    View PubMed
  11. Schinstock CA, Albright RC, Williams AW, Dillon JJ, Bergstralh EJ, Jenson BM, McCarthy JT, Nath KA. Outcomes of arteriovenous fistula creation after the Fistula First Initiative. Clin J Am Soc Nephrol. 2011 Aug; 6 (8):1996-2002 Epub 2011 July 07
    View PubMed
  12. Rogers J, Gallaher EJ, Hocum C, Steensma DP, Chrisope TR, Dingli D, McCarthy JT. Individualized medicine and biophysical system dynamics: An example from clinical practice in end-stage renal disease. (Accessed March 8 http//wwwsystemdynamicsorg/conferences/2011/proceed/papers/P1299pdf)Conference Proceedings of the 29th International Conference of the System Dynamics Society, Washington, DC. July 25-29, 2011.
  13. Jaber BL, Lee Y, Collins AJ, Hull AR, Kraus MA, McCarthy J, Miller BW, Spry L, Finkelstein FO, FREEDOM Study Group. Effect of daily hemodialysis on depressive symptoms and postdialysis recovery time: interim report from the FREEDOM (Following Rehabilitation, Economics and Everyday-Dialysis Outcome Measurements) Study. Am J Kidney Dis. 2010 Sep; 56(3):531-9. Epub 2010 Jul 29.
    View PubMed
  14. Jaber BL, Finkelstein FO, Glickman J, Hull AR, Kraus MA, Leypoldt JK, McCarthy J, Miller B, Moran J, Collins A. Scope and design of the FREEDOM (Following Rehabilitation, Economics and Everyday-Dialysis Outcome Measurements) Study. Am J Kidney Dis. 2009; 53(2):310-320.
  15. McCarthy JT, Rule AD, Achenbach SJ, Bergstralh EJ, Khosla S, Melton LJ 3rd. Use of renal function measurements for assessing fracture risk in postmenopausal women. Mayo Clin Proc. 2008 Nov; 83 (11):1231-9
    View PubMed
  16. Weenig RH, Sewell LD, Davis MD, McCarthy JT, Pittelkow MR. Calciphylaxis: natural history, risk factor analysis, and outcome. J Am Acad Dermatol. 2007 Apr; 56 (4):569-79 Epub 2006 Dec 01
    View PubMed
  17. Shrader MW, Schall D, Parvizi J, McCarthy JT, Lewallen DG. Total hip arthroplasty in patients with renal failure: a comparison between transplant and dialysis patients. J Arthroplasty. 2006 Apr; 21 (3):324-9
    View PubMed
  18. Pena de la Vega L, Miller RS, Benda MM, Grill DE, Johnson MG, McCarthy JT, McBane RD 2nd. Association of heparin-dependent antibodies and adverse outcomes in hemodialysis patients: a population-based study. Mayo Clin Proc. 2005 Aug; 80 (8):995-1000
    View PubMed
  19. Young EW, Akiba T, Albert JM, McCarthy JT, Kerr PG, Mendelssohn DC, Jadoul M. Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2004 Nov; 44(5 Suppl 2):S34-8.
  20. Edson RS, Brey RH, McDonald TJ, Terrell CL, McCarthy JT, Thibert JM. Vestibular toxicity due to inhaled tobramycin in a patient with renal insufficiency. Mayo Clin Proc. 2004 Sep; 79(9):1185-91.
    View PubMed
  21. Vautour LM, Melton LJ 3rd, Clarke BL, Achenbach SJ, Oberg AL, McCarthy JT. Long-term fracture risk following renal transplantation: a population-based study. Osteoporos Int. 2004 Feb; 15 (2):160-7 Epub 2003 Dec 09
    View PubMed
  22. Martin KJ, Olgaard K, McCarthy JT, Bone Turnover Work Group. Diagnosis, assessment, and treatment of bone turnover abnormalities in renal osteodystrophy. Am J Kidney Diseases. 2004; 43(3):558-565.
  23. Chertow GM, Raggi P, McCarthy JT, Schulman G, Silberzweig J, Kuhlik A, Goodman WG, Boulay A, Burke SK, Toto RD. The effects of sevelamer and calcium acetate on proxies of atherosclerotic and arteriosclerotic vascular disease in hemodialysis patients. Am J Nephrol. 2003 Sep-Oct; 23(5):307-14.
    View PubMed
  24. Ireland JH, McCarthy JT. Infective Endocarditis in Patients with Kidney Failure: Chronic Dialysis and Kidney Transplant. Curr Infect Dis Rep. 2003 Aug; 5 (4):293-299
    View PubMed
  25. Leypoldt JK, Jaber BL, Lysaght MJ, McCarthy JT, Moran J. Kinetics and dosing predictions for daily haemofiltration. Nephrol Dial Transplant. 2003 Apr; 18(4):769-76.
    View PubMed
  26. McCarthy JT, Moran J, Posen G, Leypoldt JK, Hull A, Japer BL, Correa-Rotter R. Time for discovery: the use of chronic hemofiltration for end-stage renal disease patients. Seminars in Dialysis. 2003; 16(3):199-207.
  27. Sorom AJ, Hughes CB, McCarthy JT, Jenson BM, Prieto M, Panneton JM, Sterioff S, Stegall MD, Nyberg SL. Prospective, randomized evaluation of a cuffed expanded polytetrafluoroethylene graft for hemodialysis vascular access. Surgery. 2002 Aug; 132 (2):135-40
    View PubMed
  28. Johnson CA, McCarthy JT, Bailie GR, Deane J, Carlson D. Analysis of renal bone disease treatment in dialysis patients. Am J Kidney Diseases. 2002; 39(6):1270-1277.
  29. Nyberg SL, Hughes CB, Valenzuela YM, Jenson BM, Benda MM, McCarthy JT, Sterioff S, Stegall MD. Preliminary experience with a cuffed ePTFE graft for hemodialysis vascular access. ASAIO J. 2001 Jul-Aug; 47 (4):333-7
    View PubMed
  30. Ting HH, Tahirkheli NK, Berger PB, McCarthy JT, Timimi FK, Mathew V, Rihal CS, Hasdai D, Holmes DR Jr, Holmes DR Jr. Evaluation of long-term survival after successful percutaneous coronary intervention among patients with chronic renal failure. Am J Cardiol. 2001 Mar 1; 87 (5):630-3, A9
    View PubMed
  31. Kang AS, McCarthy JT, Rowland C, Farley DR, van Heerden JA. Is calciphylaxis best treated surgically or medically? Surgery. 2000 Dec; 128(6):967-71;discussion 971-2.
    View PubMed
  32. Albright RC Jr, Smelser JM, McCarthy JT, Homburger HA, Bergstralh EJ, Larson TS. Patient survival and renal recovery in acute renal failure: randomized comparison of cellulose acetate and polysulfone membrane dialyzers. Mayo Clin Proc. 2000 Nov; 75(11):1141-7.
    View PubMed
  33. McCarthy JT, Regnier CE, Loebertmann CL, Bergstralh EJ. Adverse events in chronic hemodialysis patients receiving intravenous iron dextran--a comparison of two products. Am J Nephrol. 2000 Nov-Dec; 20 (6):455-62
    View PubMed
  34. McCarthy JT, Steckelberg JM. Infective endocarditis in patients receiving long-term hemodialysis. Mayo Clin Proc. 2000 Oct; 75(10):1008-14.
    View PubMed
  35. Agmon Y, Oh JK, McCarthy JT, Khandheria BK, Bailey KR, Seward JB. Effect of volume reduction on mitral annular diastolic velocities in hemodialysis patients. Am J Cardiol. 2000 Mar 1; 85 (5):665-8, A11
    View PubMed
  36. Adey D, Kumar R, McCarthy JT, Nair KS. Reduced synthesis of muscle proteins in chronic renal failure. Am J Physiol Endocrinol Metab. 2000 Feb; 278 (2):E219-25
    View PubMed
  37. McCarthy JT. Chronic renal failure: Do our residents know BEANS? Journal of Pelvic Surgery. 2000; 6 (2):93-7
  38. Williams AW, O'Sullivan DA, McCarthy JT. Slow nocturnal and short daily hemodialysis: a comparison. Semin Dial. 1999 Nov-Dec; 12(6):431-39.
  39. McCarthy JT. A practical approach to the management of patients with chronic renal failure. Mayo Clin Proc. 1999 Mar; 74(3):269-73.
    View PubMed
  40. O'Sullivan DA, McCarthy JT, Kumar R, Williams AW. Improved biochemical variables, nutrient intake, and hormonal factors in slow nocturnal hemodialysis: a pilot study. Mayo Clin Proc. 1998 Nov; 73: (11)1035-45.
    View PubMed
  41. Pardi DS, Tremaine WJ, Sandborn WJ, McCarthy JT. Renal and urologic complications of inflammatory bowel disease. Am J Gastroenterol. 1998 Apr; 93 (4):504-14
    View PubMed
  42. McCarthy JT, Jenson BM, Squillace DP, Williams AW. Improved preservation of residual renal function in chronic hemodialysis patients using polysulfone dialyzers. Am J Kidney Dis. 1997 Apr; 29 (4):576-83
    View PubMed
  43. McCarthy JT. Anemia, cardiovascular disease, and erythropoietin therapy in chronic renal failure patients. ACC Current Journal Review. 1997; 6(6):29-32.
  44. McCarthy JT. Renal replacement therapy in acute renal failure. Curr Opin Nephrol Hypertens. 1996 Nov; 5 (6):480-4
    View PubMed
  45. Kane WJ, Petty PM, Sterioff S, McCarthy JT, Crotty TB. The uremic gangrene syndrome: improved healing in spontaneously forming wounds following subtotal parathyroidectomy. Plast Reconstr Surg. 1996 Sep; 98 (4):671-8
    View PubMed
  46. Radford MG Jr, Holley KE, Grande JP, Larson TS, Wagoner RD, Donadio JV, McCarthy JT. Reversible membranous nephropathy associated with the use of nonsteroidal anti-inflammatory drugs. JAMA. 1996 Aug 14; 276 (6):466-9
    View PubMed
  47. McCarthy JT. Prognosis of patients with acute renal failure in the intensive-care unit: a tale of two eras. Mayo Clin Proc. 1996 Feb; 71 (2):117-26
    View PubMed
  48. Stevens G, Meier BJ, McCarthy JT, Carlson D. Using comparative facility review to improve dialysis patient outcomes. Dialysis and Transplantation. 1996; 25(9):568-78.
  49. Clarke BL, Muhs JM, O'Connell MJ, McCarthy JT, O'Fallon WM, Riggs BL. Assessment of bone resorption in metabolic bone disorders using a new enzyme immunoassay for urinary free pyridinoline: comparison with standard methods of assessment of bone formation. Endocr Pract. 1995 Jul-Aug; 1(4):248-56.
  50. McCarthy JT, Dayton JM, Fitzpatrick LA, Gamble GL, Gonyea JE, Jenson BM, McLeod RA. The importance of bone biopsy in managing renal osteodystrophy. Adv Ren Replace Ther. 1995 Apr; 2 (2):148-59
    View PubMed
  51. Kollmorgen CF, Aust MR, Ferreiro JA, McCarthy JT, van Heerden JA. Parathyromatosis: a rare yet important cause of persistent or recurrent hyperparathyroidism. Surgery. 1994 Jul; 116: (1)111-5.
    View PubMed
  52. McCarthy JT, Williams A, Johnson WJ. Serum beta (2)-microglobulin concentration in dialysis patients--importance of intrinsic renal function. J Lab Clin Med. 1994 Apr; 123:495-505.
    View PubMed
  53. Jenson BM, Dobbe SA, Squillace DP, McCarthy JT. Clinical benefits of high and variable sodium concentration dialysate in hemodialysis patients. ANNA J. 1994 Apr; 21(2):115-20; discussion 121.
    View PubMed
  54. Romanski SA, McCarthy JT, Kluge K, Fitzpatrick LA. Detection of subtle aluminum-related renal osteodystrophy. Mayo Clin Proc. 1993 May; 68 (5):419-26
    View PubMed
  55. McCarthy JT, Williams A. Recombinant human erythropoietin (EPO). The Practice of Internal Medicine-1992. 1992 May 11-15; 277-85.
  56. Oesterling JE, Keating JP, Leroy AJ, Earle JD, Farrow GM, McCarthy JT, Silverstein MN. Idiopathic myelofibrosis with myeloid metaplasia involving the renal pelves, ureters and bladder. J Urol. 1992 May; 147 (5):1360-2
    View PubMed
  57. McCarthy JT, Hodgson SF, Fairbanks VF, Moyer TP. Clinical and histologic features of iron-related bone disease in dialysis patients. Am J Kidney Dis. 1991 May; 17 (5):551-61
    View PubMed
  58. Marco-Franco JE, Torres VE, Nixon DE, Wilson DM, James EM, Bergstralh EJ, McCarthy JT. Oxalate, silicon and vanadium in acquired cystic kidney disease. Clin Nephrol. 1991 Feb; 35: (2)52-8.
    View PubMed
  59. Zachariah PK, Moyer TP, Theobald HM, Frantz RP, Kurtz SB, McCarthy JT, Smith RL. The pharmacokinetics of racemic verapamil in patients with impaired renal function. J Clin Pharmacol. 1991 Jan; 31 (1):45-53
    View PubMed
  60. Schmidt DF, Schniepp BJ, Kurtz SB, McCarthy JT. Inaccurate blood flow rate during rapid hemodialysis. Am J Kidney Dis. 1991 Jan; 17 (1):34-7
    View PubMed
  61. Johnson WJ, McCarthy JT, Yanagihara T, Osmundson PJ, Ilstrup DM, Jenson BM, Bowie EJ. Effects of recombinant human erythropoietin on cerebral and cutaneous blood flow and on blood coagulability. Kidney Int. 1990 Nov; 38 (5):919-24
    View PubMed
  62. Rastogi S, Atkinson JL, McCarthy JT. Allergic nephropathy associated with ciprofloxacin. Mayo Clin Proc. 1990 Jul; 65 (7):987-9
    View PubMed
  63. McCarthy JT, Kumar R. Renal osteodystrophy. Endocrinol Metab Clin North Am. 1990 Mar; 19: (1)65-93.
    View PubMed
  64. McCarthy JT, Milliner DS, Johnson WJ. Clinical experience with desferrioxamine in dialysis patients with aluminium toxicity. Q J Med. 1990 Mar; 74(275):257-76.
    View PubMed
  65. Wilkowski MJ, Velosa JA, Holley KE, Offord KP, Chu CP, Torres VE, McCarthy JT, Donadio JV Jr, Wagoner RD. Risk factors in idiopathic renal vasculitis and glomerulonephritis. Kidney Int. 1989 Dec; 36 (6):1133-41
    View PubMed
  66. Nixon DE, Moyer TP, Squillace DP, McCarthy JT. Determination of serum nickel by graphite furnace atomic absorption spectrometry with Zeeman-effect background correction: values in a normal population and a population undergoing dialysis. Analyst. 1989 Dec; 114(12):1671-4.
    View PubMed
  67. McCarthy JT, Johnson WJ, Nixon DE, Jenson BM, Moyer TP. Transfusional iron overload in patients undergoing dialysis: treatment with erythropoietin and phlebotomy. J Lab Clin Med. 1989 Aug; 114 (2):193-9
    View PubMed
  68. McCarthy JT, Klee GG, Kao PC, Hodgson SF. Serum bioactive parathyroid hormone in hemodialysis patients. J Clin Endocrinol Metab. 1989 Feb; 68(2):340-5.
    View PubMed
  69. McCarthy JT, Johnson WJ, Nixon D, Jenson B. The use of erythropoietin and phlebotomy for treatment of hemosiderosis in dialysis patients. J Lab Clin Med. 1989; 114(2):193-199.
  70. McCarthy JT, Milliner DS, Schmidt DF, Schniepp BJ, Kurtz SB, Johnson WJ. Deferoxamine and coated charcoal hemoperfusion to remove aluminum in dialysis patients. Kidney Int. 1988 Dec; 34 (6):804-8
    View PubMed
  71. McCarthy JT, Dahlberg PJ, Kriegshauser JS, Valente RM, Swee RG, O'Duffy JD, Kurtz SB, Johnson WJ. Erosive spondyloarthropathy in long-term dialysis patients: relationship to severe hyperparathyroidism. Mayo Clin Proc. 1988 May; 63 (5):446-52
    View PubMed
  72. Rakela J, Kurtz SB, McCarthy JT, Krom RA, Baldus WP, McGill DB, Perrault J, Milliner DS. Postdilution hemofiltration in the management of acute hepatic failure: a pilot study. Mayo Clin Proc. 1988 Feb; 63 (2):113-8
    View PubMed
  73. Johnson WJ, McCarthy JT, van Heerden JA, Sterioff S, Grant CS, Kao PC. Results of subtotal parathyroidectomy in hemodialysis patients. Am J Med. 1988 Jan; 84 (1):23-32
    View PubMed
  74. Kriegshauser JS, Swee RG, McCarthy JT, Hauser MF. Aluminum toxicity in patients undergoing dialysis: radiographic findings and prediction of bone biopsy results. Radiology. 1987 Aug; 164(2):399-403.
    View PubMed
  75. McCarthy JT, Kurtz SB, Mussman GV. Deferoxamine-enhanced fecal losses of aluminum and iron in a patient undergoing continuous ambulatory peritoneal dialysis. Am J Med. 1987 Feb; 82(2):367-70.
    View PubMed
  76. McCarthy JT, Milliner DS, Kurtz SB, Johnson WJ, Moyer TP. Interpretation of serum aluminum values in dialysis patients. Am J Clin Pathol. 1986 Nov; 86(5):629-36.
    View PubMed
  77. Rakela J, Kurtz SB, McCarthy JT, Ludwig J, Ascher NL, Bloomer JR, Claus PL. Fulminant Wilson's disease treated with postdilution hemofiltration and orthotopic liver transplantation. Gastroenterology. 1986 Jun; 90(6):2004-7.
    View PubMed
  78. McCarthy JT, Staats BA. Pulmonary hypertension, hemolytic anemia, and renal failure. A mitomycin-associated syndrome. Chest. 1986 Apr; 89(4):608-11.
    View PubMed
  79. McCarthy JT, Kumar R. Behavior of the vitamin D endocrine system in the development of renal osteodystrophy. Semin Nephrol. 1986 Mar; 6:21-30.
    View PubMed
  80. McCarthy JT, Kurtz SB, Johnson WJ, Moyer TP. Serum aluminum levels (SAI) in dialysis patients. Kidney Int. 1986; 29(1):165.
  81. Hodgson SF, Johnson KA, Muhs JM, Lufkin EG, McCarthy JT. Outpatient percutaneous biopsy of the iliac crest: methods, morbidity, and patient acceptance. Mayo Clin Proc. 1986 Jan; 61(1):28-33.
    View PubMed
  82. McCarthy JT, Kurtz SB, McCall JT. Elevated bone aluminum content in dialysis patients without osteomalacia. Mayo Clin Proc. 1985 May; 60(5):315-20.
    View PubMed
  83. McCarthy JT, Barham SS, Kumar R. 1,25-Dihydroxyvitamin D3 rapidly alters the morphology of the duodenal mucosa of rachitic chicks: evidence for novel effects of 1,25- dihydroxyvitamin D3. J Steroid Biochem. 1984 Sep; 21(3):253-8.
    View PubMed
  84. Kurtz SB, Wong VH, Anderson CF, Vogel JP, McCarthy JT, Mitchell JC, Kumar R, Johnson WJ. Continuous ambulatory peritoneal dialysis: three years' experience at the Mayo Clinic. Mayo Clin Proc. 1983 Oct; 58:633-639.
    View PubMed
  85. McCarthy JT, Libertin CR, Mitchell JC 3rd, Fairbanks VF. Hemosiderosis in a dialysis patient: treatment with hemofiltration and deferoxamine chelation therapy. Mayo Clin Proc. 1982 Jul; 57: (7)439-41.
    View PubMed
  86. McCarthy JT, Schwartz GL, Blair TJ, Pierides AM, Van den Berg CJ. Reversible nonoliguric acute renal failure associated with zomepirac therapy. Mayo Clin Proc. 1982 Jun; 57(6):351-4.
    View PubMed
  87. McCarthy JT, Torres VE, Romero JC, Wochos DN, Velosa JA. Acute intrinsic renal failure induced by indomethacin: role of prostaglandin synthetase inhibition. Mayo Clin Proc. 1982 May; 57(5):289-96.
    View PubMed
  88. Kurtz SB, McCarthy JT, Kumar R. Hypercalcemia in continuous ambulatory peritoneal dialysis (CAPD). Patients: observations on parameters of calcium metabolism. Int Congr Ser. 1981; 567:467-72.
PST-20219877